On the occasion of World TB day TBVI reaffirms its commitment to accelerate TB vaccine R&D through partnership to make available safe, effective and affordable TB vaccines to contribute to [...]
EC investments in TB vaccine Research and Development through TBVI and its R&D partners have resulted in 6 TB vaccines currently being evaluated in clinical trials making up almost 50% of the [...]
The annual TBVI/TBVAC 2020 meeting was held in Les Diablerets, Switzerland from Feb 1-5 2016: 167 participants from 18 countries worldwide; participants represented 58 research [...]
This is a press release from our Research partners Institut Pasteur (Paris) and CNRS. It is the disappearance of a glycolipid from the bacterial cell envelope during evolution that may have [...]
Nacho Aguilo from our research partner University of Zaragoza has been selected as the inaugural recipient of the CTVD Early Career Scientist Award for his contributions to research in TB [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
